» Articles » PMID: 30048777

Curcumin-entrapped MUC-1 Aptamer Targeted Dendrimer-gold Hybrid Nanostructure As a Theranostic System for Colon Adenocarcinoma

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2018 Jul 27
PMID 30048777
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Gold NPs have great potential in biomedical applications. PAMAM dendrimers are spherical, hyper branched macromolecules which can encapsulate therapeutic molecules while stabilizing metal nanoparticle such as gold NPs. The aim of the current study was to investigate the theranostic capability of curcumin-loaded dendrimer-gold hybrid structure. Dendrimer-gold hybrid structure was synthesized by complexing AuCl ions with PEGylated amine-terminated generation 5 poly (amidoamine) dendrimer. The resultant hybrid system was loaded with curcumin. The curcumin-loaded PEGylated Au dendrimer was further conjugated to MUC-1 aptamer in order to target the colorectal adenocarcinoma in vitro and in vivo. Obtained results demonstrated that the targeted theranostic agent was accumulated in HT29 and C26 cells in vitro and showed higher cellular cytotoxicity in comparison with non-targeted system. On the other hand, in vivo experiment demonstrated the potential of targeted theranostic system in CT-scan tumor imaging as well as cancer therapy. Findings from this study suggested that MUC-1 targeted curcumin-loaded PEGylated Au dendrimers have good X-ray attenuation and is desirable probe for CT imaging while demonstrating high therapeutic index against colorectal cancer adenocarcinoma.

Citing Articles

The potential of curcumin in mitigating acetaminophen-induced liver damage.

Einafshar E, Bahrami P, Pashaei F, Naseri P, Ay Gharanjik A, Mirteimoori A Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40009170 DOI: 10.1007/s00210-025-03907-4.


An updated landscape on nanopharmaceutical delivery for mitigation of colon cancer.

Shahzad M, Hameed H, Amjad A, Khan M, Qureshi I, Hameed A Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39361171 DOI: 10.1007/s00210-024-03482-0.


Management of Colorectal Cancer Using Nanocarriers-based Drug Delivery for Herbal Bioactives: Current and Emerging Approaches.

Deshmukh R, Prajapati M, Harwansh R Curr Pharm Biotechnol. 2024; 25(5):599-622.

PMID: 38807329 DOI: 10.2174/0113892010242028231002075512.


Tumor versus Tumor Cell Targeting in Metal-Based Nanoparticles for Cancer Theranostics.

Urbano-Gamez J, Guzzi C, Bernal M, Solivera J, Martinez-Zubiaurre I, Caro C Int J Mol Sci. 2024; 25(10).

PMID: 38791253 PMC: 11121233. DOI: 10.3390/ijms25105213.


Aptamers for the Delivery of Plant-Based Compounds: A Review.

Gamboa J, Lourenco P, Cruz C, Gallardo E Pharmaceutics. 2024; 16(4).

PMID: 38675202 PMC: 11053555. DOI: 10.3390/pharmaceutics16040541.